Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer.

导出 LinkOut

翻译打印收藏纠错

作者： Robin A,Laskey ^[1] ; Marek S,Poniewierski ; Micael A,Lopez ; Rabbie K,Hanna ; Angeles Alvarez,Secord ; Paola A,Gehrig ; Gary H,Lyman ; Laura J,Havrilesky

作者单位： Department of Obstetrics and Gynecology, Duke University Medical Center, USA. ^[1]

主题词老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);女(雌)性(Female);发热(Fever);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);人类(Humans);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);中性粒细胞减少(Neutropenia);卵巢肿瘤(Ovarian Neoplasms);试验预期值(Predictive Value of Tests);回顾性研究(Retrospective Studies);危险因素(Risk Factors)

DOI 10.1016/j.ygyno.2012.03.015

PMID 22426251

发布时间 2012-05-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览8

Gynecologic oncology

2012年125卷3期

625-30页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer.

Gynecologic oncology

相似文献

Gynecologic oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer.

Gynecologic oncology

相似文献

Gynecologic oncology

相关期刊

检索历史清除